10x Genomics, under the leadership of co-founder and CEO Serge Saxonov, PhD, is making a strategic shift towards enhancing customer support and expanding its presence in the biopharma market. Following a prolific year of product launches in 2024, the company is now focusing on promoting its recent
On Thursday, the Food and Drug Administration approved Journavx, a highly anticipated non-opioid pain medication developed by Vertex Pharmaceuticals, marking a significant milestone in the effort to shift pain treatment away from opioids. This new drug has been initially approved to treat acute
The current landscape of behavioral health startups is marked by a competitive funding environment. Companies in this sector face numerous challenges as they strive to secure capital, navigate investment trends, and differentiate themselves in a crowded market. This article explores these dynamics,
Teladoc Health, a prominent player in the telehealth market, has been navigating a challenging financial landscape while striving to maintain its expansive reach and drive future growth. With 93 million members and 10,000 customers, the company has a significant presence in the virtual healthcare
The global digital health industry is on the brink of a remarkable growth trajectory, with its market value expected to surge from USD 8,131.3 million in 2024 to USD 16,603.7 million by 2034. This substantial rise represents a compound annual growth rate (CAGR) of 7.4% over the forecast period,
Mexico is at the forefront of a digital health revolution, particularly in the realm of Electronic Health Records (EHR). This rapid transformation is driven by a combination of government initiatives, regulatory changes, and a growing demand for modernized healthcare systems. The country’s
